Human occupational exposure to sufficiently high levels of arsenic in air has been associated with lung cancer, but generally not other types of cancer. Thus, a better understanding of the relationship between airborne arsenic exposures and systemic uptake is essential. In this study, rabbits were exposed to one of four levels of arsenic trioxide in air for 8 h/day, 7 days/week, for 8 weeks (0.05, 0.1, 0.22, or 1.1 mg/m3). Plasma levels of inorganic arsenic, monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA) were measured following the last exposure. Although there was a dose-related increase in plasma levels of methylated arsenic metabolites, statistically significant increases in mean inorganic arsenic levels in plasma were observed only in male rabbits exposed to 0.22 mg/m3, and in both males and females exposed to 1.1 mg/m3. Mean inorganic arsenic levels in plasma in males and females exposed to 0.05 and 0.1 mg/m3, and females exposed to 0.22 mg/m3, were not significantly elevated compared to controls. These results suggest that arsenic inhalation has a negligible impact on body burden of inorganic arsenic until air levels are significantly elevated. Based on plasma measurements of inorganic arsenic, the two lowest exposure levels in this study (0.05 and 0.1 mg/m3) are indistinguishable from background.
Syracuse Research. Toxicological profile for arsenic. Atlanta: Agency for Toxic Substances and Disease Registry (ATSDR), 2000.
2.
US Environmental Protection Agency (US EPA). Integrated Risk Information System (IRIS)–arsenic, inorganic. 2001. http://www.epa.gov/iris/subst/0278.htm. Last updated 4/10/98.
3.
Frost F , Harter L , Milham S , et al. Lung cancer among women residing close to an arsenic emitting copper smelter . Arch Environ Health1987; 42: 148–152 .
4.
Greaves WW , Rom WN , Lyon JL , Varley G , Wright DD , Chiu G.Relationship between lung cancer and distance of residence from nonferrous smelter stack effluent . Am J Ind Med1981; 2: 15–23 .
5.
Rom WN , Varley G , Lyon JL , Shopkow S.Lung cancer mortality among residents living near the El Paso smelter . Br J Ind Med1982; 39: 269–72 .
6.
Valentine R , Kennedy GL . Chapter 23–inhalation toxicology. In Hayes AW ed. Principles and methods of toxicology, fourth edition. Philadelphia: Taylor and Francis , 2001: 1085–1043.
7.
Menzel DB , Amdur MO . Chapter 12–toxic responses of the respiratory system. In Klassen CD , Amdur MO , Doull J eds. Casarett and Doull's toxicology–the basic science of poisons, third edition. New York: Macmillan , 1986: 330–358.
8.
Polissar L , Lowry-Coble K , Kalman DA , et al. Pathways of human exposure to arsenic in a community surrounding a copper smelter . Environ Res1990; 53: 29–47 .
9.
Yager JW , Hicks JB , Fabianova E.Airborne arsenic and urinary excretion of arsenic metabolites during boiler cleaning operations in a Slovak coal-fired power plant . Environ Health Perspect1997; 105: 836–842 .
10.
Vahter M.Metabolism of arsenic. In Fowler BA ed. Biological and environmental effects of arsenic. New York: Elsevier , 1983: 171–197.
11.
National Research Council, Subcommittee on Arsenic in Drinking Water. Arsenic in drinking water. Washington, DC: National Academy Press , 1999.
12.
Vahter M.Species differences in the metabolism of arsenic compounds . Appl Organomet Chem1994; 8: 172–182 .
13.
Mann S , Droz PO , Vahter M.A physiologically based pharmacokinetic model for arsenic exposure: I. Development in hamsters and rabbits . Toxicol Appl Pharmacol1996; 137: 8–22 .
14.
Vahter M.Methylation of inorganic arsenic in different mammalian species and population groups . Sci Prog1999; 82: 69–88 .
15.
Vahter M , Marafante E , Lindgren A , Dencker L.Tissue distribution and subcellular binding of arsenic in Marmoset monkeys after injection of 74As–arsenite . Arch Toxicol1982; 51: 65–77 .
16.
Lubin JH , Pottern LM , Stone BJ , Fraumeni JF . Respiratory cancer in a cohort of copper smelter workers: results from more than 50 years of follow-up . Am J Epidemiol2000; 151: 554–65 .
17.
American Conference of Governmental Industrial Hygienists (ACGIH). Guide to occupational exposure values. Cincinnati: ACGIH , 2000.
18.
Animal Welfare . Title 9 CFR (code of federal regulations), Parts 1–3. Washington, D.C.: US Government Printing Office , 2001.
19.
US Environmental Protection Agency (US EPA). Chemical speciation of arsenic in water and tissue by hydride generation quartz furnace atomic absorption spectrometry, revision A. Washington, D.C.: US EPA, Office of Water , 2000.
20.
Battelle Pacific Northwest Laboratories. Speciation of selenium and arsenic in natural waters and sediments. Sequim, WA: Electric Power Research Institute (EPRI), 1986.
21.
Good Laboratory Practice Standards. Title 40 code of federal regulations, parts 160 and 792, 2001.
22.
Organisation for Economic Co-operation and Development (OECD). OECD series on principles of good laboratory practice and compliance monitoring, no. 1. Paris: OECD1998.
23.
Snedecor GW , Cochran WG . One way classifications: analysis of variance. Statistical methods, seventh edition. Ames, IA: Iowa State University Press , 1980: 215–237.
24.
Dunnett CW . New tables for multiple comparisons with a control . Biometrics1964; 20: 482–91 .
25.
US Environmental Protection Agency (US EPA). USEPA contract laboratory program national functional guidelines for inorganic data review. Washington, DC: Office of Emergency and Remedial Response , 1994.
26.
US Environmental Protection Agency (US EPA). Guidance for data usability in risk assessment. Washington, DC: Office of Emergency and Remedial Response , 1992.
27.
SAS Institute . SAS/STAT1 software: changes and enhancements through release 6.12. Cary, NC: SAS Institute , 1997.
28.
Vahter ME . Arsenic . In Clarkson TW , Friberg L , Nordberg GF , Sager PR eds. Biological monitoring of toxic metals. New York: Plenum , 1988: 303–21.
29.
Vahter M , Norin H.Metabolism of 74As-labeled trivalent and pentavalent inorganic arsenic in mice . Environ Res1980; 21: 446–457 .
30.
Mealey J , Brownell GL , Sweet WH . Radioarsenic in plasma, urine, normal tissues, and intracranial neoplasms . Arch Neurol Psychiatry1959; 81: 310–320 .
31.
Ducoff HS , Neal WB , Straube RL , Jacobson LO , Brues AM . Biological studies with arsenic76: II. Excretion and tissue localization . Proc Soc Exp Biol Med1948; 69: 548–554 .
32.
Vahter M , Norin H.Metabolism of 74As-labeled trivalent and pentavalent inorganic arsenic in mice . Environ Res1980; 21: 446–457 .
33.
Marafante E , Vahter M , Envall J.The role of the methylation in the detoxification of arsenate in the rabbit . Chem-Biol Interact1985; 56: 225–238 .
34.
Bertolero F , Marafante E , Rade JE , Pietra R , Sabbioni E.Biotransformation and intracellular binding of arsenic in tissues of rabbits after intraperitoneal administration of 74As labelled arsenite . Toxicology1981; 20: 35–44 .
35.
Healy SM , Casarez EA , Ayala-Fierro F , Aposhian H.Enzymatic methylation of arsenic compounds: V. Arsenite methyltransferase activity in tissues of mice . Toxicol Appl Pharmacol1998; 148: 65–70 .
36.
Styblo M , Del Razo LM , Vega L , et al. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells . Arch Toxicol2000; 74: 289–99 .
37.
Aposhian HV , Zheng B , Aposhian MM , et al. DMPS–arsenic challenge test: II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine . Toxicol Appl Pharmacol2000; 165: 74–83 .
38.
Del Razo LM , Styblo M , Cullen WR , Thomas DJ . Determination of trivalent methylated arsenicals in biological matrices . Toxicol Appl Pharmacol2001; 174: 282–293 .
39.
Le XC , Ma M , Cullen WR , Aposhian HV , Lu X , Zheng B.Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine . Environ Health Perspect2000; 108: 1015–18 .
40.
Petrick JS , Ayala-Fierro F , Cullen WR , Carter DE , Vasken Aposhian H.Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes . Toxicol Appl Pharmacol2000; 163: 203–207 .
41.
Vega L , Styblo M , Patterson R , Cullen W , Wang C , Germolec D.Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes . Toxicol Appl Pharmacol2001; 172: 225–232 .
42.
Yamanaka K , Takabayashi F , Mizoi M , An Y , Hasegawa A , Okada S.Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-oxo-20-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis . Biochem Biophys Res Commun2001; 287: 66–70 .
43.
Moore MM , Harrington-Brock K , Doerr CL . Relative genotoxic potency of arsenic and its methylated metabolites . Mutat Res1997; 386: 279–90 .
44.
Oya-Ohta Y , Kaise T , Ochi T.Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction . Mutat Res1996; 357: 123–129 .
45.
Endo G , Kuroda K , Okamoto A , Horiguchi S.Dimethylarsenic acid induces tetraploids in Chinese hamster cells . Bull Environ Contam Toxicol1992; 48: 131–137 .
46.
Mass MJ , Tennant A , Roop BC , et al. Methylated trivalent arsenic species are genotoxic . Chem Res Toxicol2001; 14: 355–61 .
47.
Hayashi H , Kanisawa M , Yamanaka K , et al. Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice . Cancer Lett1998; 125: 83–88 .
48.
Wei M , Wanibuchi H , Yamamoto S , Li W , Fukushima S.Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats . Carcinogenesis1999; 20: 1873–1876 .
49.
Yamamoto S , Konishi Y , Matsuda T , et al. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens . Cancer Res1995; 55: 1271–1276 .
50.
Yamanaka K , Mizol M , Kato K , Hasegawa A , Nakano M , Okada S.Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter . Biol Pharm Bull2001; 24: 510–14 .
51.
Kenyon EM , Hughes MF . A concise review of the toxicity and carcinogenicity of dimethylarsinic acid . Toxicology2001; 160: 227–236 .
52.
Kitchin KT . Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites . Toxicol Appl Pharmacol2001; 172: 249–61 .
53.
Thomas DJ , Styblo M , Lin S.The cellular metabolism and systemic toxicity of arsenic . Toxicol Appl Pharmacol2001; 176: 127–144 .
54.
Del Razo LM , Garcia-Vargas GG , Vargas H , et al. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism . A pilot study. Arch Toxicol1997; 71: 211–217 .
55.
Hsueh YM , Chiou HY , Huang YL , et al. Serum betacarotene level, arsenic methylation capability, and incidence of skin cancer . Cancer Epidemiol Biomarkers Prev1997; 6: 589–96 .
56.
Yu RC , Hsu KH , Chen CJ , Froines JR . Arsenic methylation capacity and skin cancer . Cancer Epidemiol Biomarkers Prev2000; 9: 1259–1262 .
57.
Wu MM , Chiou HY , Wang TW , et al. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan . Environ Health Perspect2001; 109: 1011–1017 .
58.
US Environmental Protection Agency (US EPA). Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. Washington, DC: Office of Research and Development , 1994.
59.
Binder S , Forney D , Kaye W , Paschal D.Arsenic exposure in children living near a former copper smelter . Bull Environ Contam Toxicol1987; 39: 114–121 .
60.
Binder S.The case for the NEDEL (the no epidemiologically detectable exposure level). Am J Public Health1988; 78: 589–590 .
61.
Enterline PE , Marsh GM . Cancer among workers exposed to arsenic and other substances in a copper smelter . Am J Epidemiol1982; 116: 895–911 .
62.
Enterline PE , Henderson VL , Marsh GM . Exposure to arsenic and respiratory cancer. A reanalysis . Am J Epidemiol1987; 125: 929–38 .
63.
Enterline PE , Marsh GM , Esmen NA , Henderson VL , Callahan CM , Paik M.Some effects of cigarette smoking, arsenic, and SO2 on mortality among US copper smelter workers . J Occup Med1987; 29: 831–38 .
64.
Lee-Feldstein A.Arsenic and respiratory cancer in humans: follow-up of copper smelter employees in Montana . J Natl Cancer Inst1983; 70: 601–10 .
65.
Jarup L , Pershagen G , Wall S.Cumulative arsenic exposure and lung cancer in smelter workers: a dose–response study . Am J Ind Med1989; 15: 31–41 .
66.
Chen CJ , Chen CW , Wu MM , Kuo TL . Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water . Br J Cancer1992; 66: 888–92 .
67.
Guo HR , Chiang HS , Hu H , Lipsitz SR , Monson RR . Arsenic in drinking water and incidence of urinary cancers . Epidemiology1997; 8: 545–550 .
68.
Hopenhayn-Rich C , Biggs ML , Fuchs A , et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina . Epidemiology1996; 7: 117–124 .
69.
Hopenhayn-Rich C , Biggs ML , Smith AH . Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina . Int J Epidemiol1998; 27: 561–569 .
70.
Smith AH , Goycolea M , Haque R , Biggs ML . Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water . Am J Epidemiol1998; 147: 660–669 .
71.
Tseng WP , Chu HM , How SW , Fong JM , Lin CS , Yeh S.Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan . J Natl Cancer Inst1968; 40: 453–63 .
72.
Tseng WP . Effects and dose–response relationships of skin cancer and blackfoot disease with arsenic . Environ Health Perspect1977; 19: 109–19 .
73.
Wu MM , Kuo TL , Hwang YH , Chen CJ . Dose–response relation between arsenic concentration in well water and mortality from cancers and vascular diseases . Am J Epidemiol1989; 130: 1123–1132 .
74.
Feldman RG , Niles CA , Kelly-Hayes M , et al. Peripheral neuropathy in arsenic smelter workers . Neurology1979; 29: 939–44 .
75.
Vahter M , Envall J.In vivo reduction of arsenate in mice and rabbits . Environ Res1983; 32: 14–24 .
76.
Vahter M , Lind B.Concentrations of arsenic in urine of the general population in Sweden . Sci Total Environ1986; 54: 1–12 .
77.
Kalman DA , Hughes J,van Belle G , et al. The effect of variable environmental arsenic contamination on urinary concentrations of arsenic species . Environ Health Perspect1990; 89: 145–51 .
78.
Hsu KH , Froines JR , Chen CJ . Studies of arsenic ingestion from drinking water in northeastern Taiwan: chemical speciation and urinary metabolites. In Abernathy CO , Calderon RL , Chappell WR eds. Arsenic: exposure and health effects. London: Chapman and Hall , 1997: 190–209.
79.
Calderon RL , Hudgens E , Le XC , Schreinemachers D , Thomas DJ . Excretion of arsenic in urine as a function of exposure to arsenic in drinking water . Environ Health Perspect1999; 107: 663–667 .
